Skip to main content
SpringerLink
Log in

The therapeutic role of lasers in primary localized cutaneous amyloidosis: a systematic review

  • Review Article
  • Published:
Lasers in Medical Science Aims and scope Submit manuscript

Abstract

With the investigation of the efficacy of laser therapy in primary localized amyloidosis(PLCA) only recently starting to materialize, we aimed to review the currently available studies of laser therapy in the management of the disease. We searched PubMed, Scopus, Embase, Web of Science, Cochrane, and ProQuest online databases with a specified search strategy, assessed the quality of each study, and then extracted the eligible data. Five RCTs(randomized controlled trials), one non-randomized controlled trial, three case series, and nine case reports(18 in total) were included. Overall, carbon dioxide (CO2), neodymium-doped:yttrium aluminum garnet (Nd:YAG), pulsed dye (PDL), Er (Erbium):YAG, and yttrium/erbium fiber were the studied lasers. One hundred fifty-five cases in total underwent laser therapy, with CO2 being the most frequent laser. Almost all studies demonstrated significantly desirable outcomes, while only mild and transient side effects were noted. Even though the studies’ results were significant, we noticed that implementing a consistent methodology and a standardized objective assessment method was missing. Therefore, we recommend that future studies be conducted with less heterogeneous data for a more definite conclusion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data availability

The dataset supporting the conclusions of this article (i.e., data extracted from included studies) is available upon request to the corresponding author, Mohammad Shafie'ei.

Code availability

Not applicable.

References

  1. Borowicz J, Gillespie M, Miller R (2011) Cutaneous amyloidosis. Skinmed 9(2):96–100 (quiz 1)

    PubMed  Google Scholar 

  2. Mehrotra K, Dewan R, Kumar JV, Dewan A (2017) Primary cutaneous amyloidosis: a clinical, histopathological and immunofluorescence study. J Clin Diagn Res 11(8):Wc01-wc5

    PubMed  PubMed Central  Google Scholar 

  3. Sarkany RPE, Breathnach SM, Morris AAM, Weismann K, Flynn PD. Metabolic and nutritional disorders. Rook’s Textbook of Dermatology. 2010:1–103.

  4. Chiti F, Dobson CM (2017) Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu Rev Biochem 86:27–68

    Article  CAS  Google Scholar 

  5. Li WM (1990) Histopathology of primary cutaneous amyloidoses and systemic amyloidosis. Clin Dermatol 8(2):30–35

    Article  CAS  Google Scholar 

  6. Terushkin V, Boyd KP, Patel RR, McLellan B (2013) Primary localized cutaneous amyloidosis. Dermatol Online J 19(12):20711

    Article  Google Scholar 

  7. Bolognia JL, Schaffer JV, Cerroni L. Dermatology: Elsevier; 2017.

  8. Ollague W, Ollague J, Ferretti H (1990) Epidemiology of primary cutaneous amyloidoses in South America. Clin Dermatol 8(2):25–29

    Article  CAS  Google Scholar 

  9. Tan T (1990) Epidemiology of primary cutaneous amyloidoses in southeast Asia. Clin Dermatol 8(2):20–24

    Article  CAS  Google Scholar 

  10. Konopinski JC, Seyfer SJ, Robbins KL, Hsu S (2013) A case of nodular cutaneous amyloidosis and review of the literature. Dermatol Online J 19(4):10

    Article  Google Scholar 

  11. Kaltoft B, Schmidt G, Lauritzen AF, Gimsing P (2013) Primary localised cutaneous amyloidosis–a systematic review. Dan Med J 60(11):A4727

    PubMed  Google Scholar 

  12. Moon AO, Calamia KT, Walsh JS (2003) Nodular amyloidosis: review and long-term follow-up of 16 cases. Arch Dermatol 139(9):1157–1159

    Article  Google Scholar 

  13. Fang S, Shen X, Chen AJ, Li S, Shan K (2015) Health-related quality of life in patients with primary cutaneous amyloidosis. PLoS One. 10(3):e0120623

    Article  Google Scholar 

  14. Saki N, Ahramiyanpour N, Heiran A, Alipour S, Parvizi MM (2020) Efficacy of topical dimethyl sulfoxide (DMSO) 50% solution vs tretinoin 0.5% cream in treatment of patients with primary macular amyloidosis: a split-side single-blinded randomized clinical trial. Dermatologic Therapy 33(3):e13305

    Article  CAS  Google Scholar 

  15. Weidner T, Illing T, Elsner P (2017) Primary localized cutaneous amyloidosis: a systematic treatment review. Am J Clin Dermatol 18(5):629–642

    Article  Google Scholar 

  16. Tanzi EL, Lupton JR, Alster TS (2003) Lasers in dermatology: four decades of progress. J Am Acad Dermatol. 49(1):1–31 (quiz -4)

    Article  Google Scholar 

  17. Al Yahya RS (2016) Treatment of primary cutaneous amyloidosis with laser: a review of the literature. Lasers Med Sci 31(5):1027–1035

    Article  Google Scholar 

  18. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine. 6(7):e1000097

    Article  Google Scholar 

  19. Ostovari N, Mohtasham N, Oadras MS, Malekzad F (2008) 532-nm and 1064-nm Q-switched Nd:YAG laser therapy for reduction of pigmentation in macular amyloidosis patches. J Eur Acad Dermatol Venereol 22(4):442–446

    Article  CAS  Google Scholar 

  20. Barsky M, Buka RL (2014) Pulsed dye laser for the treatment of macular amyloidosis: a case report. Cutis 93(4):189–192

    PubMed  Google Scholar 

  21. Khurana N, Urman C (2016) The efficacy of Q-switched ND:YAG 1064 nm laser in recalcitrant macular amyloidosis: a case report. J Drugs Dermatol 15(11):1456–1458

    PubMed  Google Scholar 

  22. Nilforoushzadeh MA, Zolghadr S, Heidari-Kharaji M, Alavi S, Mahmoudbeyk M (2020) A comparative study of the efficacy of fractional neodymium-doped yttrium aluminum garnet (Nd:YAG) laser therapy alone and in combination with erbium:YAG laser therapy: tracing and objective measurement of melanin index in macular amyloidosis. Lasers Med Sci 35(5):1171–1177

    Article  Google Scholar 

  23. Nahidi Y, Delghandi SR, Kiafar B, Saki A (2021) The therapeutic effects of 1540-nm non-ablative fractional erbium laser on macular amyloidosis: a randomized clinical trial. J Dermatolog Treat 32(3):340–344

    Article  CAS  Google Scholar 

  24. Sobhi RM, Sharaoui I, El Nabarawy EA, Esmail RSE, Hegazy RA, Aref DHF (2018) Comparative study of fractional CO2 laser and fractional CO2 laser-assisted drug delivery of topical steroid and topical vitamin C in macular amyloidosis. Lasers Med Sci 33(4):909–916

    Article  Google Scholar 

  25. Anitha B, Mysore V (2012) Lichen amyloidosis: novel treatment with fractional ablative 2,940 nm erbium: YAG laser treatment. J Cutan Aesthet Surg 5(2):141–143

    Article  CAS  Google Scholar 

  26. Korbi M, Akkari H, Soua Y, Mohamed M, Youssef M, Belhajdali H et al (2019) Lichen amyloidosis successfully treated with fractional ablative laser CO2: a new alternative therapeutic. J Cosmet Laser Ther 21(1):1–3

    Article  Google Scholar 

  27. Liu HT (2000) Treatment of lichen amyloidosis (LA) and disseminated superficial porokeratosis (DSP) with frequency-doubled Q-switched Nd:YAG laser. Dermatol Surg 26(10):958–962

    Article  CAS  Google Scholar 

  28. Norisugi O, Yamakoshi T, Shimizu T (2014) Successful treatment of lichen amyloidosis using a CO2 surgical laser. Dermatol Ther 27(2):71–73

    Article  Google Scholar 

  29. Panchaprateep R, Tusgate S, Munavalli GS, Noppakun N (2015) Fractional 1,550nm ytterbium/erbium fiber laser in the treatment of lichen amyloidosis: clinical and histological study. Lasers Surg Med 47(3):222–230

    Article  Google Scholar 

  30. Esmat SM, Fawzi MM, Gawdat HI, Ali HS, Sayed SS (2015) Efficacy of different modes of fractional CO2 laser in the treatment of primary cutaneous amyloidosis: a randomized clinical trial. Lasers Surg Med 47(5):388–395

    Article  Google Scholar 

  31. Fawzi MMT, Gawdat HI, Mahmoud SB, El-Hawary MS, Rashed LA, Esmat SM (2021) Fractional carbon dioxide laser is effective in amelioration of pruritus in primary cutaneous amyloidosis: a clinical and biochemical study. Lasers Surg Med 53(4):482–487

    Article  Google Scholar 

  32. Fawzy MM, Kamel MM, El Maadawi Z, Abdel Hady R, Osman MA. Fractional erbium-doped yttrium aluminum garnet laser in the treatment of primary cutaneous amyloidosis. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al]. 2021.

  33. Alster TS, Manaloto RMP (1999) Nodular amyloidosis treated with a pulsed dye laser. Dermatol Surg 25(2):133–135

    Article  CAS  Google Scholar 

  34. Hamzavi I, Lui H (1999) Excess tissue friability during CO2 laser vaporization of nodular amyloidosis. Dermatol Surg 25(9):726–728

    Article  CAS  Google Scholar 

  35. Lesiak A, Rakowski A, Brzezinska A, Rogowski-Tylman M, Kolano P, Sysa-Jedrzejowska A et al (2012) Effective treatment of nodular amyloidosis with carbon dioxide laser. J Cutan Med Surg 16(5):372–374

    Article  Google Scholar 

  36. Truhan AP, Garden JM, Roenigk HH Jr (1986) Nodular primary localized cutaneous amyloidosis: immunohistochemical evaluation and treatment with the carbon dioxide laser. J Am Acad Dermatol 14(6):1058–1062

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Afzalipour Hospital, Afzalipour Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran

    Najmeh Ahramiyanpour & Mahin Aflatoonian

  2. Faculty of Medicine, Kerman University of Medical Sciences, Haft Bagh Alavi Blvd, Postal Code: 7616913555, Kerman, Iran

    Zahra Akbari, Mohammad Sharifi Sarasyabi & Mohammad Shafie’ei

  3. Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

    Nasrin Saki

  4. Dermatology Department, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

    Nasrin Saki

Authors
  1. Najmeh Ahramiyanpour
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zahra Akbari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohammad Sharifi Sarasyabi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mahin Aflatoonian
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nasrin Saki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mohammad Shafie’ei
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors participated in designing the protocol. First, NA, MS, and ZA designed the study. MS, ZA, and MSS then did the literature search. NA, MS, ZA, and MSS selected the studies and extracted the relevant information, then assessed and confirmed by the senior authors. All authors then participated in synthesizing the data. MS and NA also wrote the first draft of the paper. NA, NS, and MA provided critical guidance on the analysis and overall direction of the study. All authors critically revised successive drafts of the paper and approved the final version.

Corresponding author

Correspondence to Mohammad Shafie’ei.

Ethics declarations

Additional declarations for articles in life science journals that report the results of studies involving humans and/or animals.

Not applicable.

Ethics approval

No ethical approval was required as this manuscript is a review article with no original research data.

Consent to participate

Not applicable.

Consent for publication

All named authors take responsibility for the integrity of the work as a whole. They have given their consent for this version to be published.

Conflict of interest

The authors declare no competing interests.

Authorship

All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahramiyanpour, N., Akbari, Z., Sarasyabi, M.S. et al. The therapeutic role of lasers in primary localized cutaneous amyloidosis: a systematic review. Lasers Med Sci 37, 799–813 (2022). https://doi.org/10.1007/s10103-021-03429-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10103-021-03429-4

Keywords

Search

Navigation